A study led by researchers from the Institut de Neurociències (INc-UAB), in collaboration with the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), describes a new mechanism by which the an...
The biopharmaceutical company Ability Pharmaceuticals SL announced today that the full description of the mechanism of action of ABTL0812 has been published in the prestigious Autophagy journal (impac...
The COST Action PROTEOSTASIS BM1307, coordinated by Dr. Rosa Barrio (group leader at CIC bioGUNE) ended on the 24th of April 2018. This European network gathered 274 group members from almost all coun...
Researchers at the Pharmacology Unit IRBLleida have trials with several models of cell cultures, including some derived from tumors of patients, exposing them to media without nutrients and trophic fa...